The Call for Opposition: Challenging the P2P and IOM Processes
In our second article on how to react to the publication of the draft P2P report, Gabby Klein provides her view of why she and a large group of advocates and patients are continuing their protest of the government’s ongoing control and manipulation of our disease via their processes...
Discuss the article on the Forums.

Prof. Jonas Blomberg lectures- any questions?

Discussion in 'Latest ME/CFS Research' started by Helen, Mar 27, 2014.

  1. Helen

    Helen Senior Member

    Messages:
    676
    Likes:
    799
    Hi all,

    Today I recieved an invitation from the ME/CFS group in Gothenburg, to a 2-hour lecture April, 9.
    Prof. Jonas Blomberg will spend two hours with us (a rather small group) explaining his latest study "in layman terms". It was presented here
    http://forums.phoenixrising.me/inde...sh-me-cfs-study-indicates-autoimmunity.26986/

    If you have any questions I will try to get them answered. The study was a bit over my head so I´m looking forward getting a simplified presentation.

    Prof. Blomberg will also talk at the ME conference in London in May
    http://www.investinme.eu/agenda.html#Conference_Programme

    Best
    Helen
     
    ukxmrv, NK17 and Sasha like this.
  2. natasa778

    natasa778 Senior Member

    Messages:
    1,567
    Likes:
    1,555
    London UK
    Q:

    wrt his findings, is he aware of research on purinergic antagonist Suramin used to address mitochondrial dysfunction-neuroinflammation, and if he thinks this would be worth pursuing in ME?


    ATP signaling modulates immune responses and chronic inflammation, as well as anti-viral signaling, microglial activation, gut motility and permeability, and sensitivity to food allergens. Suramin inhibits purinergic signaling and has been used for treating African Sleeping Sickness (Trypanosomiasis) since the early 1900s. Treating the offspring of maternal immune activated mice weekly with suramin normalizes their social behavior, motor coordination, body temperature, mitochondrial respiratory function and other metabolic measures. Most impressively, this treatment also corrects a neuropathology ...





    Full paper
     
    cigana and NK17 like this.
  3. natasa778

    natasa778 Senior Member

    Messages:
    1,567
    Likes:
    1,555
    London UK
    I feel MITOKINES and purinergic signalling is a huge unexplored area in ME, spanning across mito, neuroinflammatory, gut and infection/immune areas and so has a big treatment potential ...


    Thank you!
     
    NK17 likes this.
  4. Helen

    Helen Senior Member

    Messages:
    676
    Likes:
    799
    Hi @natasa778,

    Thank you for the question and information that sound quite interesting. I hope Prof. Blomberg also finds it worth considering and that I will have a response in some weeks
     
    natasa778 likes this.
  5. cigana

    cigana Senior Member

    Messages:
    779
    Likes:
    454
    UK
    Did he ever comment on @natasa778 's question?
     

See more popular forum discussions.

Share This Page